BASETROPHY GP (08460) announced on December 9, 2025, that it entered into a placing agreement with a placing agent. The company agreed to make a subscription offer, while the placing agent agreed to use reasonable efforts to secure at least six placees for up to 44.268 million placing shares at HK$0.437 per share. The placees and their ultimate beneficial owners must be independent third parties. The placing shares will be allotted and issued under the general mandate.

The maximum of 44.268 million placing shares represents: - 20.00% of the company's existing issued share capital (221 million shares) as of the announcement date; and - approximately 16.67% of the enlarged issued share capital (assuming no other changes occur between the announcement date and the completion of the placing).

The total nominal value of the placing shares will be HK$44.268 million. Assuming full subscription, the gross proceeds will be approximately HK$19.3628 million, with net proceeds (after deducting placing fees and expenses) estimated at HK$17.886 million.

Net proceeds are intended for working capital and potential future investments, though no specific investment targets have been identified as of the announcement date. The placing price of HK$0.437 per share was determined through arm's-length negotiations between the company and the placing agent, representing: - a 19.07% discount to the closing price of HK$0.54 per share on December 9, 2025 (the placing agreement date); and - a 17.86% discount to the five-day average closing price of HK$0.532 per share preceding the agreement date.